FI62307C - Foerfarande foer framstaellning av spiro(kroman- eller -tiokroman-4,4'-imidazolidin)-2' 5'-dioner och dylika tiokromaners oxidationsprodukter vilka aer anvaendbara vid behandling av diabetes - Google Patents

Foerfarande foer framstaellning av spiro(kroman- eller -tiokroman-4,4'-imidazolidin)-2' 5'-dioner och dylika tiokromaners oxidationsprodukter vilka aer anvaendbara vid behandling av diabetes Download PDF

Info

Publication number
FI62307C
FI62307C FI773060A FI773060A FI62307C FI 62307 C FI62307 C FI 62307C FI 773060 A FI773060 A FI 773060A FI 773060 A FI773060 A FI 773060A FI 62307 C FI62307 C FI 62307C
Authority
FI
Finland
Prior art keywords
compound
imidazolidine
dione
diabetes
spiro
Prior art date
Application number
FI773060A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI773060A (fi
FI62307B (fi
Inventor
Reinhard Sarges
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/767,803 external-priority patent/US4117230A/en
Application filed by Pfizer filed Critical Pfizer
Publication of FI773060A publication Critical patent/FI773060A/fi
Priority to FI810088A priority Critical patent/FI63579C/fi
Priority to FI812208A priority patent/FI73981C/fi
Application granted granted Critical
Publication of FI62307B publication Critical patent/FI62307B/fi
Publication of FI62307C publication Critical patent/FI62307C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/10—Spiro-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Ophthalmology & Optometry (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
FI773060A 1976-10-18 1977-10-14 Foerfarande foer framstaellning av spiro(kroman- eller -tiokroman-4,4'-imidazolidin)-2' 5'-dioner och dylika tiokromaners oxidationsprodukter vilka aer anvaendbara vid behandling av diabetes FI62307C (fi)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FI810088A FI63579C (fi) 1976-10-18 1981-01-14 Foerfarande foer framstaellning av en ny terapeutiskt anvaendbar spiro-benso(b)tiofen(3,4')imidazolidin-2,5-dion-1,1-dioxid
FI812208A FI73981C (fi) 1976-10-18 1981-07-14 Foerfarande foer framstaellning av nya, vid behandling av diabetes anvaendbara spiro(imidazolidinindan eller -hydronaftalen)-2,5-dionderivat.

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US73306276A 1976-10-18 1976-10-18
US73306276 1976-10-18
US05/767,803 US4117230A (en) 1976-10-18 1977-02-11 Hydantoin derivatives as therapeutic agents
US76780377 1977-02-11

Publications (3)

Publication Number Publication Date
FI773060A FI773060A (fi) 1978-04-19
FI62307B FI62307B (fi) 1982-08-31
FI62307C true FI62307C (fi) 1982-12-10

Family

ID=27112515

Family Applications (1)

Application Number Title Priority Date Filing Date
FI773060A FI62307C (fi) 1976-10-18 1977-10-14 Foerfarande foer framstaellning av spiro(kroman- eller -tiokroman-4,4'-imidazolidin)-2' 5'-dioner och dylika tiokromaners oxidationsprodukter vilka aer anvaendbara vid behandling av diabetes

Country Status (29)

Country Link
JP (3) JPS5353653A (fr)
AR (1) AR220901A1 (fr)
AT (1) AT356136B (fr)
AU (1) AU504978B2 (fr)
BG (1) BG28847A3 (fr)
CA (1) CA1088945A (fr)
CH (1) CH625511A5 (fr)
DD (1) DD131931A5 (fr)
DE (4) DE2746244C2 (fr)
DK (1) DK150302C (fr)
ES (1) ES463267A1 (fr)
FI (1) FI62307C (fr)
FR (1) FR2367754A1 (fr)
GB (1) GB1566171A (fr)
GR (1) GR70201B (fr)
HK (1) HK53881A (fr)
IE (1) IE45805B1 (fr)
IL (1) IL53094A0 (fr)
KE (1) KE3167A (fr)
LU (1) LU78330A1 (fr)
MX (1) MX4899E (fr)
MY (1) MY8200157A (fr)
NL (1) NL167434C (fr)
NO (1) NO148453C (fr)
NZ (1) NZ185358A (fr)
PH (1) PH15639A (fr)
PT (1) PT67164B (fr)
SE (1) SE437024B (fr)
YU (1) YU40821B (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4130714A (en) * 1977-05-23 1978-12-19 Pfizer Inc. Hydantoin therapeutic agents
US4127665A (en) * 1978-01-18 1978-11-28 Pfizer Inc. Thienohydantoin derivatives
US4147797A (en) * 1978-08-11 1979-04-03 Pfizer Inc. Spiro-furanohydantoin derivatives
US4200642A (en) * 1978-08-21 1980-04-29 Pfizer Inc. Spiro-oxazolidindiones
US4181728A (en) * 1978-11-16 1980-01-01 Pfizer Inc. Spiro-polycyclicimidazolidinedione derivatives
US4181729A (en) * 1979-03-21 1980-01-01 Pfizer Inc. Phenyl or phenoxy substituted spiro-imidazolidinedione derivatives
US4235911A (en) * 1979-06-13 1980-11-25 Pfizer Inc. Hydantoin derivatives
US4283409A (en) * 1979-10-29 1981-08-11 Pfizer Inc. Imidazolone derivatives
US4286098A (en) * 1980-03-28 1981-08-25 Pfizer Inc. Process for the preparation of chiral hydantoins
JPS5745185A (en) * 1980-07-21 1982-03-13 Eisai Co Ltd Hydantoin derivative and its preparation
EP0065392B1 (fr) * 1981-05-13 1985-02-13 Imperial Chemical Industries Plc Compositions pharmaceutiques contenant des dérivés de la spiro-succinimide
JPS58213717A (ja) * 1982-01-20 1983-12-12 Eisai Co Ltd ヒダントイン誘導体を含有する治療用薬剤
JPS59500617A (ja) * 1982-04-15 1984-04-12 アルコン・ラボラトリ−ズ・インコ−ポレ−テッド ヒダントイン治療剤
HU193191B (en) * 1982-12-06 1987-08-28 Pfizer Process for preparing spiro-hetero-azolones
US4474967A (en) * 1983-04-27 1984-10-02 Pfizer Inc. 8-Deutero and 8-tritio-substituted derivatives of D-4S-6-fluoro-spiro-[chroman-4,4'-imidazolidine]-2',5'-dione
WO1986002647A1 (fr) * 1984-10-30 1986-05-09 Pfizer Inc. Utilisation de spiro-heteroazolones dans le traitement des complications dues au diabete
JPS61200991A (ja) * 1985-03-04 1986-09-05 Sanwa Kagaku Kenkyusho:Kk スピロ―３―ヘテロアゾリジン化合物、その製法及びそれを有効成分とする糖尿病合併症の予防及び治療剤
US4575507A (en) * 1985-05-29 1986-03-11 Pfizer Inc. Spiro-imidazolidines as aldose reductase inhibitors and their pharmaceutical use
JPS6357588A (ja) * 1986-08-28 1988-03-12 Sanwa Kagaku Kenkyusho Co Ltd ヒダントイン誘導体、その塩並びに該化合物を有効成分とする糖尿病合併症の予防及び治療剤
HU204832B (en) * 1987-09-04 1992-02-28 Pfizer Process for producing spiro-(imidazolidine-4,4'-pyrano/2,3-b/pyridine) derivatives and pharmaceutical compositions comprising same
GB2355264A (en) 1999-09-30 2001-04-18 Merck & Co Inc Spirohydantoin derivatives useful as alpha 1a adrenoceptor antagonists
CN1659136A (zh) * 2002-04-18 2005-08-24 弗吉尼亚大学专利基金会 新的钠通道阻滞剂
FR2955107B1 (fr) 2010-01-08 2012-03-02 Servier Lab Nouveaux derives thiochromanes, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB818724A (en) * 1956-10-18 1959-08-19 Ici Ltd Hydantoin derivatives
DE1135915B (de) * 1961-06-29 1962-09-06 Asta Werke Ag Chem Fab Verfahren zur Herstellung neuer, antikonvulsiv wirksamer Spirohydantoine
US3532744A (en) * 1967-07-28 1970-10-06 American Home Prod 1- and 2-amino substituted indane and tetralene carboxylic acids
US3821383A (en) * 1972-07-10 1974-06-28 Ayerst Mckenna & Harrison Compositions for and a method of treating diabetic complications
DE2449030A1 (de) * 1974-10-11 1976-05-20 Schering Ag Neue pyridin-derivate
US4130714A (en) * 1977-05-23 1978-12-19 Pfizer Inc. Hydantoin therapeutic agents

Also Published As

Publication number Publication date
DK150302B (da) 1987-02-02
FR2367754A1 (fr) 1978-05-12
SE437024B (sv) 1985-02-04
AR220901A1 (es) 1980-12-15
NO773548L (no) 1978-04-19
DK461377A (da) 1978-04-19
MY8200157A (en) 1982-12-31
JPS5495570A (en) 1979-07-28
PT67164B (en) 1979-03-20
AU504978B2 (en) 1979-11-01
IL53094A0 (en) 1977-12-30
DE2759543C2 (fr) 1987-04-09
SE7711053L (sv) 1978-04-19
JPS5940388B2 (ja) 1984-09-29
IE45805B1 (en) 1982-12-01
JPS5353653A (en) 1978-05-16
DE2759542C2 (fr) 1988-07-07
YU244277A (en) 1982-08-31
ES463267A1 (es) 1978-07-16
JPS5495575A (en) 1979-07-28
DK150302C (da) 1987-09-28
DE2746244A1 (de) 1978-04-20
GR70201B (fr) 1982-08-31
BG28847A3 (en) 1980-07-15
YU40821B (en) 1986-06-30
MX4899E (es) 1982-12-14
DD131931A5 (de) 1978-08-09
HK53881A (en) 1981-11-13
CA1088945A (fr) 1980-11-04
NO148453C (no) 1983-10-12
ATA745977A (de) 1979-09-15
IE45805L (en) 1978-04-18
JPS5534132B2 (fr) 1980-09-04
CH625511A5 (en) 1981-09-30
LU78330A1 (fr) 1979-06-01
NO148453B (no) 1983-07-04
AT356136B (de) 1980-04-10
AU2943177A (en) 1979-04-12
PT67164A (en) 1977-11-01
NL167434C (nl) 1981-12-16
DE2746244C2 (de) 1983-05-19
FI773060A (fi) 1978-04-19
PH15639A (en) 1983-03-11
FR2367754B1 (fr) 1982-07-09
GB1566171A (en) 1980-04-30
NL167434B (nl) 1981-07-16
DE2759927C2 (de) 1986-12-04
NZ185358A (en) 1979-06-08
KE3167A (en) 1981-11-06
JPS607997B2 (ja) 1985-02-28
NL7711358A (nl) 1978-04-20
FI62307B (fi) 1982-08-31

Similar Documents

Publication Publication Date Title
FI62307C (fi) Foerfarande foer framstaellning av spiro(kroman- eller -tiokroman-4,4'-imidazolidin)-2' 5'-dioner och dylika tiokromaners oxidationsprodukter vilka aer anvaendbara vid behandling av diabetes
FI62838C (fi) Foerfarande foer framstaellning av den nya farmaceutiskt anvaendbara hoegerroterande isomeren av en asymmetriskt spiro-hydantoinfoerening
US4117230A (en) Hydantoin derivatives as therapeutic agents
US4147795A (en) Hydantoin derivatives as therapeutic agents
EP0193415B1 (fr) Composés de spiro-3-hétéroazolidine et leurs sels, leur préparation et agents pharmaceutiques les contenant
FI65255C (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara spiro(4h-2,3-dihydrobenzopyran(4,5')oxazolidin)-2',4'-dioner
IE47726B1 (en) Thienohydantoin derivatives
FI66385B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara spro(imidazolidin-4,4'-(4'h)-naftopyran (och naftotiopyran) )-,5-dion-derivat
US7329654B2 (en) Heteroatom containing tetracyclic derivatives as selective estrogen receptor modulators
EP0264586A1 (fr) Dérivés de l'hydantoine pour le traîtement de complications du diabète
FI71139B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara haogensubstituerade bensonpyran- bensotiopyran- eller 2h-na ft/1,2-b/pyran-4-karboxylsyror
EP0008229B1 (fr) Dérivés de la spiro-furanohydantoine, procédé pour leur préparation et compositions pharmaceutiques les contenant
US20040259915A1 (en) Novel heteroatom containing tetracyclic derivatives as selective estrogen receptor modulators
US4209630A (en) Hydantoin derivatives as therapeutic agents
EP1467998B1 (fr) Hetero-composes tetracycliques utilisables comme modulateurs du recepteur des oestrogenes
US6071953A (en) Sulfonamide-substituted chromans, processes for their preparation, their use as medicament or diagnostic aid, and medicament comprising them
EP0014079B1 (fr) Spiro-quinolylhydantoines, procédé pour leur préparation et leurs compositions pharmaceutiques
PL147399B1 (en) Method of obtaining novel derivatives of spiro imidazolidine
EP0339358B1 (fr) Mevalonolactones du type pyrazolopyridine
US4282229A (en) Hydantoin derivatives as therapeutic agents
US4210756A (en) Tetrahydroquinoline hydantoins for chronic diabetic complications
US4258054A (en) Hydantoin derivatives as therapeutic agents
EP0092386B1 (fr) Agents thérapeutiques à la base d'hydantoine
KR820001306B1 (ko) 스피로-히단토인 화합물의 제조방법
FI63579B (fi) Foerfarande foer framstaellning av en ny terapeutiskt anvaendbar spiro-benso(b)tiofen(3,4')imidazolidin-2,5-dion-1,1-dioxid

Legal Events

Date Code Title Description
MM Patent lapsed
MM Patent lapsed

Owner name: PFIZER INC.